Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-14 8:24 pm Purchase |
2022-03-10 | 13D | Puma Biotechnology, Inc. PBYI |
AUERBACH ALAN H | 9,347,277 21.000% |
2,089,066 (+28.78%) |
Filing History |
| 2022-02-14 09:35 am Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,050,000 5.010% |
-505,000 (-19.77%) |
Filing History |
| 2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 0 0.000% |
-3,959,741 (Position Closed) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,680,187 9.000% |
283,498 (+8.35%) |
Filing History |
| 2022-02-10 06:31 am Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
STATE STREET CORP STT |
578,090 1.410% |
-1,663,947 (-74.22%) |
Filing History |
| 2022-02-08 4:43 pm Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
GOLDMAN SACHS GROUP INC GS |
2,097,647 5.100% |
2,097,647 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
3,204,237 7.800% |
208,222 (+6.95%) |
Filing History |
| 2022-01-14 4:08 pm Purchase |
2022-01-06 | 13G | Puma Biotechnology, Inc. PBYI |
MILLENNIUM MANAGEMENT LLC | 2,237,699 5.500% |
2,237,699 (New Position) |
Filing History |
| 2021-11-19 4:10 pm Purchase |
2021-11-10 | 13G | Puma Biotechnology, Inc. PBYI |
Integrated Core Strategies (US) LLC | 2,004,338 4.900% |
1,215,638 (+154.13%) |
Filing History |
| 2021-11-10 4:08 pm Sale |
2021-10-31 | 13G | Puma Biotechnology, Inc. PBYI |
Alger Associates, Inc. | 890,396 2.180% |
-2,525,607 (-73.93%) |
Filing History |
| 2021-02-16 4:51 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Alger Associates, Inc. | 3,416,003 8.590% |
3,416,003 (New Position) |
Filing History |
| 2021-02-16 08:21 am Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,555,000 6.430% |
155,000 (+6.46%) |
Filing History |
| 2021-02-12 3:58 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
EcoR1 Capital LLC | 0 0.000% |
-2,536,156 (Position Closed) |
Filing History |
| 2021-02-12 12:30 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 3,959,741 9.960% |
1,681,588 (+73.81%) |
Filing History |
| 2021-02-10 3:13 pm Sale |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
STATE STREET CORP STT |
2,242,037 5.640% |
-1,265,115 (-36.07%) |
Filing History |
| 2021-02-10 11:40 am Sale |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,396,689 8.540% |
-589,437 (-14.79%) |
Filing History |
| 2021-02-09 4:37 pm Sale |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Integrated Core Strategies (US) LLC | 788,700 2.000% |
-1,161,606 (-59.56%) |
Filing History |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
2,996,015 7.500% |
104,679 (+3.62%) |
Filing History |
| 2020-08-10 2:52 pm Purchase |
2020-08-07 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 2,278,153 5.740% |
2,278,153 (New Position) |
Filing History |
| 2020-06-29 6:03 pm Purchase |
2020-06-18 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,400,000 6.100% |
2,400,000 (New Position) |
Filing History |